PTC Therapeutics (PTCT) Earnings Date & Reports

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

PTCT is expected to report earnings to fall 70.05% to 27 cents per share on October 22

PTC Therapeutics PTCT Stock Earnings Reports

Q3'26

Est.

$0.28

Q2'26

Beat

by $0.60

Q1'26

Beat

by $0.43

Q4'25

Missed

by $1.41

Q3'25

Beat

by $1.32

The last earnings report on July 30 showed earnings per share of 92 cents, beating the estimate of 31 cents. With 614.98K shares outstanding, the current market capitalization sits at 5.78B.

View a ticker or compare two or three

PTCT

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days